Stimulation of a spermatogenesis in men at a pathospermia and infertility
- Autores: Rozhivanov R.V1, Kravtsova N.S1, Kurbatov D.G1
-
Afiliações:
- Edição: Nº 1S (2016): Supplement
- Páginas: 54-59
- Seção: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/286669
- ID: 286669
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
The combined therapy of HCG in combination with recombinant FSH is al most effective. At the same time the studied types of the stimulating therapy are safe and don't lead to development of side effects. The purpose: to investigate of the methods of treatment, directed on increase in quantity of spermatozoa in an ejaculate. Matherials and methods: for this purpose used clomifene and combinations of recombinant FSH with chorionic gonadotrophin (HCG) in 60 men with infertility. Results: Efficiency of monotherapy by clomiphene was higher and made 20% for conception, and 63% for oligoteratozoospermia. Efficiency of the combined therapy of HCG in combination with recombinant FSH was 40% for conception, and 87% for oligoteratozoospermia. The efficiency of the combined therapy by recombinant FSH and HCG in cases of the previous inefficiency monotherapy HCG and clomifene for oligoteratozoospermia made 65%.
Palavras-chave
Texto integral
Bibliografia
- The world Health Organization laboratory manual for the examination and processing of human semen - 5th ed. 2010; 271p.
- Nieschlag E., Behre H.M., Nieschlag S. Andrology: Male reproductive health and disfunction. Springer-Verlag Berlin Heidelberg. 2010;629. ISBN: 978-3-540-78354-1.
- Yang L., Zhang S.X., Dong Q, Xiong Z.B., Li X. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience. Int. Urol. Nephrol. 2012; 44:393-399.
- Chua M.E., Escusa K.G., Luna S., Tapia L.C., Dofitas B., Morales M. Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a meta-analysi. Andrology. 2013;1(5):749.
- Божедомов В.А., Рохликов И.М., Третьяков А.А., Липатова Н.А., Виноградов И.В., Никонов Е.Л. Актуальные вопросы оказания помощи парам с мужским фактором бездетного брака: клинические и организационно-методические аспекты. Андрология и генитальная хирургия. 2013;4:4-13
- Amirzargar М.А., Yavangi М., Basin А., Babbolhavaeji Н., Amirzargar N, Moadabshoar L. Comparison of recombinant human follicle stimulating hormone (rhFSH), human chorionic gonadotropin (HCG) and human menopausal gonadotropin (HMG) on semen parameters after varicocelectomy: a randomized clinical trial. Iran J. Reprod. Med. 2012;10(5):441-452.
- Zagarskikh E.Yu., Labygina A.V., Kurashova N.A. Experience in the treatment of normogonadotropic infertility in men. Urologiya. 2014;5:87-89. Russian (Загарских Е.Ю., Лабыгина А.В., Курашова Н.А. Опыт лечения нормогонадотропного бесплодия у мужчин. Урология. 2014;5:87-89).
- Sinisi A.A., Esposito D., Bellastella G., Maione L., Palumbo V., Gandini L., Lombardo F., De Bellis A., Lenzi A., Bellastella A. Efficacy of recombinant human follicle stimulating hormone at low doses in inducing spermatogenesis and fertility in hypogonadotropic hypogonadism. J. Endocrinol. Invest. 2010;33(9):618-623.
- Belloc S., Benkhalifa M., Cohen-Bacrie M., Dalleac A., Chahine H., Amar E., Zini A. Which isolated sperm abnormality is most related to sperm DNA damage in men presenting for infertility evaluation. J. Assist. Reprod. Genet. 2014;31(5):527-532.
- Krausz C., Giachini C. Genetic risk factors in male infertility. Arch. Androl. 2007;53(3):125-133.
Arquivos suplementares
